MA43151B1 - Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic - Google Patents

Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic

Info

Publication number
MA43151B1
MA43151B1 MA43151A MA43151A MA43151B1 MA 43151 B1 MA43151 B1 MA 43151B1 MA 43151 A MA43151 A MA 43151A MA 43151 A MA43151 A MA 43151A MA 43151 B1 MA43151 B1 MA 43151B1
Authority
MA
Morocco
Prior art keywords
monoclonal antibodies
meningitidis serogroup
nmx
relates
antibodies
Prior art date
Application number
MA43151A
Other languages
English (en)
Other versions
MA43151A (fr
Inventor
Muhamed-Kheir Taha
Alain AGNEMEMEL
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of MA43151A publication Critical patent/MA43151A/fr
Publication of MA43151B1 publication Critical patent/MA43151B1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/22—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Neisseriaceae (F), e.g. Acinetobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne des anticorps monoclonaux et des parties de liaison à l'antigène correspondantes, spécifiques pour les polysaccharides capsulaires du sérogroupe X de Neisseria meningitidis (NmX), lesdits anticorps ou les parties correspondantes étant caractérisés par les séquences des 6 CDR des régions variables des chaînes lourdes et légères. Ces anticorps conviennent pour la détection in vitro du sérogroupe X de Neisseria meningitidis, en particulier dans un échantillon biologique sans purification des polysaccharides capsulaires. L'invention concerne également lesdits anticorps monoclonaux ou les parties adéquates correspondantes dans différents tests et procédés diagnostiques en vue de détecter NmX. L'invention concerne également un test diagnostique rapide pour détecter NmX dans un fluide biologique.
MA43151A 2015-06-09 2016-06-08 Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic MA43151B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15305877 2015-06-09
PCT/EP2016/062994 WO2016198435A1 (fr) 2015-06-09 2016-06-08 Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic
EP16727523.9A EP3307774B1 (fr) 2015-06-09 2016-06-08 Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic

Publications (2)

Publication Number Publication Date
MA43151A MA43151A (fr) 2021-05-12
MA43151B1 true MA43151B1 (fr) 2025-06-30

Family

ID=53365948

Family Applications (1)

Application Number Title Priority Date Filing Date
MA43151A MA43151B1 (fr) 2015-06-09 2016-06-08 Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic

Country Status (5)

Country Link
US (1) US10613085B2 (fr)
EP (1) EP3307774B1 (fr)
ES (1) ES3024468T3 (fr)
MA (1) MA43151B1 (fr)
WO (1) WO2016198435A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
WO2015105955A1 (fr) 2014-01-08 2015-07-16 Flodesign Sonics, Inc. Dispositif d'acoustophorèse avec double chambre acoustophorétique
BR112017009931A2 (pt) 2014-11-18 2018-02-14 Pasteur Institut anticorpos policlonais, agente de diagnóstico, método de detecção de sorogrupo x de neisseria meningitidis in vitro, método in vitro de diagnóstico de infecção no sorogrupo x de neisseria meningitidis, kit e teste de diagnóstico, uso do kit de diagnóstico e método de produção de anticorpos policlonais
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
KR102439221B1 (ko) 2017-12-14 2022-09-01 프로디자인 소닉스, 인크. 음향 트랜스듀서 구동기 및 제어기
WO2020160157A1 (fr) * 2019-01-30 2020-08-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Détection de complexes hétérodimères de la famille bcl-2 et utilisation associée
CN109879961B (zh) * 2019-03-26 2022-04-26 天津喜诺生物医药有限公司 一种抗隐球菌荚膜多糖单克隆抗体及其杂交瘤细胞株制备与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017009931A2 (pt) 2014-11-18 2018-02-14 Pasteur Institut anticorpos policlonais, agente de diagnóstico, método de detecção de sorogrupo x de neisseria meningitidis in vitro, método in vitro de diagnóstico de infecção no sorogrupo x de neisseria meningitidis, kit e teste de diagnóstico, uso do kit de diagnóstico e método de produção de anticorpos policlonais

Also Published As

Publication number Publication date
MA43151A (fr) 2021-05-12
US20180180610A1 (en) 2018-06-28
ES3024468T3 (en) 2025-06-04
WO2016198435A1 (fr) 2016-12-15
EP3307774A1 (fr) 2018-04-18
US10613085B2 (en) 2020-04-07
EP3307774B1 (fr) 2025-04-30
EP3307774C0 (fr) 2025-04-30

Similar Documents

Publication Publication Date Title
MA43151B1 (fr) Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic
JP6933684B2 (ja) Ｃｄ３特異的結合ドメインによって引き起こされる潜在的有害事象を緩和するための抗白血球接着
MA42542B1 (fr) Molécules se liant à pd-1 et méthodes d'utilisation correspondantes
CY1123518T1 (el) Ανθρωπινα αντισωματα enanti-tau
CR9393A (es) Anticuerpos anti-ccr5 y usos de los mismos
ECSP11011239A (es) Proteínas ligadoras il-1
ZA201904431B (en) Early detection of glial cell activation in neurodegenerative or neuroinflammatory diseases
ATE438853T1 (de) Diagnostische testvorrichtung
RU2015103228A (ru) Антитела против тау
NO20080799L (no) Omkonstruerte antistoffer med New World primate rammeverksregioner
EA201100231A1 (ru) Диагностический анализ на основе антител
EA200901550A1 (ru) Способы лечения, диагностирования и выявления ассоциированных с fgf21 нарушений
ATE480251T1 (de) Diagnose und behandlung von malignen neoplasmen
MA40974B1 (fr) Anticorps polyclonaux spécifiques pour le sérogroupe x de n. Meningitidis et leurs utilisations dans le diagnostic
EA201000333A1 (ru) Диагностические вещества на основе композиций наночастиц для тестирования посредством оптической визуализации
DE602005021644D1 (de) Verfahren und reagentien zur diagnose von hantavirusinfektionen
WO2021122113A3 (fr) Détecteur de fuite
CY1121950T1 (el) Νεα αντισωματα εναντι φωσφορυλχολινης
CL2022003336A1 (es) Anticuerpos dirigidos a un complejo que comprende hla-i no clásico y neoantígeno y usos
Wu et al. Emerging ocular side effects of immune checkpoint inhibitors: a comprehensive review
Kim et al. Preformed angiotensin II type-1 receptor antibodies are associated with rejection after kidney transplantation: a single-center, cohort study
FR3109160B1 (fr) Dispositif de diagnostic portable en forme de boitier cylindrique et ses utilisations
FI20012603A0 (fi) Diagnostinen menetelmä
ATE554384T1 (de) Verfahren und kit für den nachweis heparinabhängiger antikörper und die diagnose von heparin-potenzierten immun- bzw. autoimmunerkrankungen wie etwa heparin-induzierte thrombopenie
EP4116441A4 (fr) Composition pour le diagnostic du sars-cov-2, kit, et procédé pour le diagnostic du sars-cov-2 l'utilisant